XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Business and Significant Accounting Policies - Revised Equity Statements and Note 10 (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2021
Sep. 30, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Jun. 30, 2021
Jun. 30, 2020
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Beginning balance $ 625,668 $ 668,560 $ 542,369 $ 668,560 $ 544,186 $ 544,186  
Net income (loss) (137,008) (47,153) 89,856 (184,161) 89,591    
Ending balance 492,404 625,668 630,970 492,404 630,970 668,560 $ 544,186
Deferred income taxes       (62,940) 24,879    
Accounts receivable       (43,429) (61,251)    
Net cash used in operating activities       (305,741) (103,148)    
Total revenue 194,981 157,526 357,565 352,508 480,339    
Life              
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Total revenue 32,780   35,666 80,211 77,094    
Final expense | Life              
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Total revenue 10,886   9,816 35,473 26,274    
Commission              
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Total revenue 140,701 132,254 320,265 272,956 425,415    
Commission | Life              
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Total revenue 27,012   29,844 67,845 66,046    
As Previously Reported              
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Beginning balance   674,889 544,974 674,889 545,689 545,689  
Net income (loss)   (45,365) 90,416   91,253    
Ending balance     634,135   634,135 674,889 545,689
Deferred income taxes         25,321    
Accounts receivable         (63,355)    
Net cash used in operating activities         (103,148)    
Total revenue   159,923 358,274   482,443    
As Previously Reported | Commission              
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Total revenue   134,651 320,974   427,519    
Adjustment              
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Beginning balance   (6,329) (2,605) (6,329) (1,503) (1,503)  
Net income (loss)   (1,788) (560)   (1,662) (4,800)  
Ending balance     (3,165)   (3,165) (6,329) (1,503)
Deferred income taxes         (442)    
Accounts receivable         2,104    
Net cash used in operating activities         0    
Total revenue   (2,397) (709)   (2,104)    
Adjustment | Commission              
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Total revenue   (2,397) (709)   (2,104) (6,100) (2,000)
Retained Earnings/(Accumulated Deficit)              
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Beginning balance 74,772 121,925 (4,560) 121,925 (4,295) (4,295)  
Net income (loss) (137,008)   89,856 (184,161) 89,591    
Ending balance $ (62,236) $ 74,772 85,296 $ (62,236) 85,296 121,925 (4,295)
Retained Earnings/(Accumulated Deficit) | As Previously Reported              
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Beginning balance     (1,955)   (2,792) (2,792)  
Net income (loss)     90,416   91,253    
Ending balance     88,461   88,461   (2,792)
Retained Earnings/(Accumulated Deficit) | Adjustment              
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Beginning balance     (2,605)   (1,503) $ (1,503)  
Net income (loss)     (560)   (1,662)    
Ending balance     $ (3,165)   $ (3,165)   $ (1,503)